Eltrombopag

Indication

Treatment of Thrombocytopenia in adults with Hepatitis C

MHRA Drug Safety Update - Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results

Red

Brand:

Revolade®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Blood and Nutrition

Background

Eltrombopag is recommended as an option for the treatment of thrombocytopenia only in adults with non-genotype 1 HCV infection who have MELD scores <10 and baseline albumin >35g/L.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Eltrombopag Hepc New Medicine Review

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Pending	Red	Red	Pending	Red	Red	Red	Pending

What do the colours mean?

Last Updated: 01 - May - 2014